MRC/ARUK Institute of Ageing and Chronic Disease, University of Liverpool
Welcome,         Profile    Billing    Logout  
 20 Trials 
3 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cooper, Robert M
AOST-2121, NCT04974008: Osteosarcoma Maintenance Therapy With OST31-164

Completed
2
39
US
OST31-164
George Clinical Pty Ltd
Bone Cancer
09/23
09/23
TEMPEST, NCT04706429 / 2020-002242-17: The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy

Active, not recruiting
2
154
Europe
Trientine, Cufence, Placebo
Manchester University NHS Foundation Trust, National Institute for Health Research, United Kingdom, University of Manchester, University of Liverpool, Univar BV, University of Oxford
Hypertrophic Cardiomyopathy
04/24
10/24
AAML1921, NCT04258943 / 2015-002916-34: Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia

Active, not recruiting
1/2
60
US
Bosutinib
Children's Oncology Group, Erasmus Medical Center, Dutch Childhood Oncology Group, Innovative Therapies for Children with Cancer, Pfizer
Philadelphia Chromosome Positive CML, Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Chronic Phase Chronic Myelogenous Leukemia
07/28
07/28

Download Options